Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia.
about
Advances in antibiotic therapy in the critically illPrecision medicine for the treatment of severe pneumonia in intensive care.Investigational drugs in phase I and phase II clincial trials for the treatment of hospital-acquired pneumonia.The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia.Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 - April 1, 2016, Tours, France.Alternatives to antibiotics.New targets for new therapeutic approaches.A New Take on an Old Remedy: Generating Antibodies against Multidrug-Resistant Gram-Negative Bacteria in a Postantibiotic World.Ventilator-associated Pneumonia Prevention. Is It Worth It?The research agenda in VAP/HAP: next steps.
P2860
Q26749328-1585FE8A-E282-45D4-BE13-1EF4B9D27DB2Q38704065-6EE4481C-BD69-496D-8B1F-231F51E82C79Q38783043-980C6CFC-0F91-4CFA-AA73-6AE64740CDEBQ40591899-A0874F1A-A3A3-4A08-BB5D-626123CA2722Q40644061-2F834308-6621-4F75-AF0C-40F9121AB415Q40733237-BCEE3638-8684-4061-8C66-C2439C65EE43Q41489649-4F379C22-45C5-4C45-8A13-FA4BC28920BDQ41989828-F9DBCA35-7071-4686-A0E4-BF896CF28A63Q46140385-5B4743BB-418E-4C28-B620-B031DD828581Q47974769-765F449B-7261-4D04-8F88-D4F773131E64
P2860
Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Assessment of panobacumab as a ...... udomonas aeruginosa pneumonia.
@en
Assessment of panobacumab as a ...... udomonas aeruginosa pneumonia.
@nl
type
label
Assessment of panobacumab as a ...... udomonas aeruginosa pneumonia.
@en
Assessment of panobacumab as a ...... udomonas aeruginosa pneumonia.
@nl
prefLabel
Assessment of panobacumab as a ...... udomonas aeruginosa pneumonia.
@en
Assessment of panobacumab as a ...... udomonas aeruginosa pneumonia.
@nl
P2093
P2860
P50
P921
P1476
Assessment of panobacumab as a ...... udomonas aeruginosa pneumonia.
@en
P2093
J-P Revelly
P Eggimann
P2860
P2888
P304
P356
10.1007/S10096-014-2156-1
P577
2014-05-24T00:00:00Z